[1]
“MOLECULAR DOCKING STUDY OF QUINOLIN-4(1H)-ONE DERIVATIVES AS VEGFR-2 INHIBITORS FOR THE TREATMENT OF LUNG CANCER”, FMHR, vol. 3, no. 6, pp. 1–15, Aug. 2025, Accessed: Mar. 09, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/712